Content about Peripheral neuropathy

November 1, 2012

Global MS market to reach $19.5 billion in 2017, report finds

The global market for treatments for neurodegenerative disorders will exceed $20 billion before the end of the decade, according to a new report.

August 29, 2012

Nucynta ER approved as neuropathic pain treatment for DPN patients

The Food and Drug Administration has approved a supplemental new drug application for an opioid analgesic to treat diabetes-related pain.

July 5, 2012

FDA approves generic version of Lyrica

The Food and Drug Administration has approved Lupin Pharmaceuticals' generic version of a drug used to treat pain and seizure disorders.

October 31, 2011

J&J submits new FDA application for Nucynta ER

A Johnson & Johnson subsidiary has sent a regulatory application to the Food and Drug Administration seeking approval for one of its drugs in treating diabetes-related pain.

June 17, 2011

Nipro, NeuroMetrix collaborate to market NC-stat DPNCheck

Nipro Diagnostics and NeuroMetrix have teamed up to market a point-of-care test that is designed to evaluate such systemic neuropathies as diabetic peripheral neuropathy.

July 19, 2010

Pfizer suspends more tanezumab trials

Drug maker Pfizer is suspending some clinical studies of a biotech drug for treating pain...